Gilbert M. Labrucherie
Independent DirectorMr. Gilbert M. Labrucherie, J.D., C.F.A., also known as Gil, is Chief Financial Officer of Septerna, Inc. from January 6,2025. He served as an Interim Chief Financial Officer of Acelyrin, Inc. since August 2, 2023 until September 2023 and served as Its Chief Financial Officer since September 2023 until January 2, 2025 and served as its Chief Business Officer since May 2024 until January 2, 2025. He served as Chief Financial Officer at Acelyrin, Inc. since July 18, 2022 until November 2022. He serves as an Independent Director of Rezolute Inc. since November 20, 2019. He had been Chief Operating Officer of Nektar Therapeutics since October 2019 until July 2022 and had been its Chief Financial Officer since June 2016 until July 2022. Mr. Labrucherie served as Senior Vice President of Nektar Therapeutics since April 2, 2007 until July 2022. Mr. Labrucherie served as a director of Valinor Pharma LLC, a company focused on innovative commercialization of medicines until its acquisition by Grunenthal in July 2024. Mr. Labrucherie has several years of senior leadership experience in finance, legal and corporate development. He served as Secretary of Nektar Therapeutics since April 2007 until June 2016 and its General Counsel since April 2, 2007 until June 2016 respectively. He served as Secretary of Senova Systems, Inc. He served as Interim Secretary of Chadmoore Wireless Group Inc. (formerly, Capvest Internationale Ltd.) since November 10, 2006 and as its Interim President from November 10, 2006 to March 26, 2007. He co-founded Senova Systems, Inc. He served as Vice President for Corporate Legal of Nektar Therapeutics since October 2005. Mr. Labrucherie began his career as an associate in the corporate practice of the law firm of Wilson Sonsini Goodrich & Rosati. From October 2000 to September 2005, he served as Vice President of Corporate Development at E2open LLC. While at E2open, he was responsible for global corporate alliances and merger and acquisition activity. He was an executive at different organizations where he was responsible for global corporate alliances and mergers and acquisitions. From September 1999 to September 2000, Mr. Labrucherie served as a Senior Director of Corporate Development at AltaVista Company (a CMGI, Inc. majority-owned subsidiary), where he was responsible for merger and acquisition transactions. He began his career as an Associate at the law firm of Wilson, Sonsini, Goodrich & Rosati Headquartered in Palo Alto, California and served in that position from 1996 to 1999. He served as Chairman of the Board at Chadmoore Wireless Group Inc. since November 10, 2006. He served as Director at Chadmoore Wireless Group Inc. since December 2002. He served as Director at Senova Systems, Inc. He was a Member of the California Law Review and Order of the Coif of the University of California Boalt Hall School of Law. He is a Member of the State Bar of California and is a Certified Management Accountant. Mr. Labrucherie is the sole trustee and executive in charge of the Bloom Trust, a closely held family office with commercial real estate assets and operations. Mr. Labrucherie received Juris Doctor degree from the University of California Berkeley Boalt Hall School of Law and a Bachelor of Arts degree from the University of California at Davis.
Positions
- Company NameRezolute, Inc.Stock CodeRZLTPositionIndependent DirectorColleagues
- NCNevan Charles ElamFounder, CEO & Acting Chairman of the Board
- DGDaron G. EvansChief Financial & Business Officer
- BKBrian Kenneth RobertsChief Medical Officer
- SKSunil KarnawatChief Commercial Officer
- MRMichael R. DeperroSenior VP & Head of Operations
- GMGilbert M. LabrucherieIndependent Director
- WHWladimir HogenhuisIndependent Director
- NCNerissa C. KreherIndependent Director
- JMJerrold M. OlefskyMember of the Scientific Advisory Board
- Company NameSepterna, Inc.Stock CodeSEPNPositionChief Financial OfficerColleagues
- JTJeffrey T. FinerCo-Founder, CEO & Director
- JKJeffrey K. TongChairman of the Board
- EPElizabeth P. BhattPresident & COO
- RJRobert J. LefkowitzCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
- ACArthur ChristopoulosCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
- PSPatrick SextonCo-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board
